PROGENICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN CALL, CUSIP 743187906.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN CALL, CUSIP 743187906.